Mobilat

Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid, Suprarenal Extract, the active ingredients in Mobilat, are a combination topical preparation presented as a dermatological cream for cutaneous use. The formulation is intended for external application to address various skin conditions and is marketed within the European Union and is supplied to healthcare professionals for prescription use.

GNH USA supplies Mobilat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mobilat is a combination topical preparation used in dermatology for the management of common skin disorders. - Acne vulgaris: reduces inflammatory lesions and comedones by promoting exfoliation and anti‑inflammatory effects. - Psoriasis: helps decrease scaling and erythema through keratolytic action and skin barrier support. - Warts (verrucae): assists in removal of hyperkeratotic tissue by softening the lesion for easier treatment.

Topical application of Mobilat may be associated with local skin reactions, ranging from mild irritation to rare severe events.

Common Side Effects: - Redness: mild erythema at the application site. - Dryness: transient skin dryness or flaking. - Tingling: brief sensation of tingling or warmth. - Pruritus: mild itching without spreading.

Serious or Rare Side Effects: - Contact dermatitis: allergic reaction with swelling and intense itching. - Bullous formation: blistering of the skin in sensitive individuals. - Hyperpigmentation: darkening of treated area after prolonged use. - Systemic toxicity: unlikely but possible salicylate accumulation with excessive application over large body surface.

When using Mobilat, certain precautions should be observed to minimize adverse reactions and ensure product stability. - Application area: limit use to affected skin and avoid mucous membranes. - Frequency: follow prescriber instructions; excessive application may increase irritation risk. - Age restrictions: not recommended for children under 12 years without medical supervision. - Concomitant therapy: avoid simultaneous use with other keratolytic or potent corticosteroid products unless directed. - Allergy screening: discontinue if signs of allergic contact dermatitis develop. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Mobilat can interact with other topical agents or systemic medications that affect skin integrity or salicylate metabolism.

Major Interactions (Avoid): - Systemic salicylates: concurrent high-dose oral aspirin may increase risk of salicylate toxicity. - Potent topical steroids: may mask irritation signs and increase skin thinning.

Moderate Interactions (Monitor Closely): - Other keratolytics (e.g., urea, alpha‑hydroxy acids): may enhance irritation. - Phototherapy: combined use can increase photosensitivity. - Anticoagulants: extensive skin application could theoretically increase systemic absorption of salicylate, affecting clotting.